Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This research developed new in vitro models for high-throughput screening of drugs that could protect or restore immune privilege in hair follicles, finding that Tofacitinib was effective in preventing inflammation-related marker upregulation, while Tacrolimus and αMSH worked specifically in outer root sheath keratinocytes.

In this case report, adult-onset porokeratotic eccrine ostial and dermal duct nevus improved with topical tazarotene treatment, as evidenced by dermatoscopic images.

This study suggests that decreased expression of thioredoxin reductase 1 in hair follicle cells may contribute to glucocorticoid resistance in some alopecia areata patients by affecting the intracellular redox system.

The trial helped find the best dose of deuruxolitinib for treating alopecia areata.

The researchers reported that QR678 Neo® combined with intralesional steroids significantly improved hair regrowth and patient satisfaction in treating alopecia areata compared to steroids alone.

This study found that pharmacopuncture and needle-embedding therapy may improve hair loss and physical condition in women with androgenetic alopecia, though further clinical research is needed.

This study expands the Drug Ontology to include therapeutic indications for resistant hypertension, malaria, and opioid abuse research, providing a framework for additional drug use representations beyond their original design.

Topical minoxidil successfully treated temporal triangular alopecia.

This case report describes a treatment approach for frontal and temporal alopecia using oral dutasteride, minoxidil lotion, and triamcinolone injections, with hyaluronic acid successfully treating injection site atrophy.

Using finasteride with TIP extends time off period for prostate cancer patients.

This article proposes a classification for small graft transplants that includes technical factors to improve communication and facilitate comparative studies, reporting no new clinical results.

This phase 2 trial found that SM04554, a Wnt signaling modulator, was well-tolerated and increased follicle counts in males with androgenetic alopecia, suggesting potential for promoting hair growth.

This case report describes two patients who experienced loose anagen hairs and pili torti, resulting in nonscarring alopecia, potentially linked to erlotinib treatment for solid tumors.

More minoxidil applied topically leads to better hair growth in male pattern baldness.

This article discusses the author's experience attending the annual Italian Society for Hair Restoration meeting and does not report any scientific findings.

This article discusses patient selection and procedural design for hair transplant surgery without reporting new clinical results; it also considers how hair transplant designs can align with various hairstyles.

This study at Gajra Raja Medical College found that topical methotrexate with tretinoin was more effective but not significantly better than betamethasone with tretinoin for treating alopecia areata over six months, with similar safety profiles between the treatments.

Olmsted syndrome can be inherited as an autosomal recessive trait due to a rare TRPV3 gene mutation.

This study found that melatonin may enhance hair follicle stem cell viability by downregulating the nuclear receptor RORA, which otherwise inhibits cell proliferation and promotes apoptosis.

This article reviews the principles of donor and recipient dominance in hair transplantation and reports no new experimental results.

This article reports on twice-weekly 5 mg betamethasone oral pulse therapy for alopecia areata but provides no clinical results.

The man's occipital hair loss was due to temporal triangular alopecia, not alopecia areata.

Oral minoxidil is a potential treatment for hair loss.

This abstract describes androgenetic alopecia, a common dermatological condition, and does not provide new clinical findings.

In this study, researchers described cases of traction alopecia in young Sikh boys due to hair tying practices, emphasizing the importance of early intervention and education to prevent progression and support hair regrowth, using strategies like changing hair tying methods and topical treatments when appropriate.

This study found that OR-101, a selective JAK3/TEK inhibitor, was associated with dose-dependent improvements in hair growth in humanized mice with alopecia areata, suggesting its potential as a treatment option.